| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/29/2004 | EP1462523A2 L-glutamic acid-producing bacterium and method for producing L-glutamic acid |
| 09/29/2004 | EP1462522A2 Maize Met-1 promoter |
| 09/29/2004 | EP1462521A1 Human p53 splice variant displaying differential transcriptional activity |
| 09/29/2004 | EP1462520A1 DNA isolation method |
| 09/29/2004 | EP1462519A1 Method and devices for producing biomolecules |
| 09/29/2004 | EP1462516A1 Mutated 6-phosphogluconate dehydrogenase |
| 09/29/2004 | EP1462457A1 Cytotoxic protein and utilization thereof |
| 09/29/2004 | EP1462175A2 Apparatus and methods for dispensing isolated droplet |
| 09/29/2004 | EP1462114A1 Methods and means to suppress symptons of an allergic disease by inhibiting the glucocorticoid-induced tumor necrosis factor receptor (GRIT or TNFRSF18) |
| 09/29/2004 | EP1462102A1 A method for promoting gonadal growth in an animal |
| 09/29/2004 | EP1461674A2 Library screening |
| 09/29/2004 | EP1461625A2 Resistance circuit stabilization and pulse duration control systems for electroporation instruments |
| 09/29/2004 | EP1461620A2 Flexible method and apparatus for high throughput production and purification of multiple proteins |
| 09/29/2004 | EP1461619A2 Improved structured-functional bonding matrices for biomolecules |
| 09/29/2004 | EP1461614A2 Functional inactivation of cxcr4-mediated responses in growth hormone transgenic mice through socs3 upregulation |
| 09/29/2004 | EP1461610A2 Heme-regulated eukaryotic initiation factor 2 alpha kinase knockout mice and methods for use |
| 09/29/2004 | EP1461596A2 Direct write nanolithographic deposition of nucleic acids from nanoscopic tips |
| 09/29/2004 | EP1461463A2 Antisense modulation of hematopoietic cell protein tyrosine kinase expression |
| 09/29/2004 | EP1461462A1 Pcr based high throughput polypeptide screening |
| 09/29/2004 | EP1461461A2 Antisense modulation of cd81 expression |
| 09/29/2004 | EP1461460A2 Methods for the identification of inhibitors of asparagine synthase, 5-aminolevulinate synthase, histidinol-phosphatase, 3-isopropylmalate and threonine synthase as antibiotics |
| 09/29/2004 | EP1461457A2 Single nucleotide polymorphisms and combinations thereof predictive for paclitaxel responsiveness |
| 09/29/2004 | EP1461456A2 Methods for the identification of genetic features for complex genetics classifiers |
| 09/29/2004 | EP1461455A2 Post-synthesis labeling of nucleic acids and uses thereof |
| 09/29/2004 | EP1461452A2 Homogeneous assay of biopolymer binding by means of multiple measurements under varied conditions |
| 09/29/2004 | EP1461451A2 Method for determining the activity of ornithine decarboxylase and for identifying effectors of ornithine decarboxylase activity |
| 09/29/2004 | EP1461450A1 T-bet compositions and methods of use thereof |
| 09/29/2004 | EP1461448A2 Diagnosis prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profiling |
| 09/29/2004 | EP1461446A2 Lipid-associated molecules |
| 09/29/2004 | EP1461445A2 Glycoprotein remodeling using endoglycanases |
| 09/29/2004 | EP1461444A2 Glycopeptide remodeling using amidases |
| 09/29/2004 | EP1461443A2 Carbohydrate-associated proteins |
| 09/29/2004 | EP1461442A2 TRANSGENIC ANIMALS BEARING HUMAN Ig Lambda LIGHT CHAIN GENES |
| 09/29/2004 | EP1461441A1 Flavivirus vaccine delivery system |
| 09/29/2004 | EP1461439A1 Method for the transformation of vegetable plastids |
| 09/29/2004 | EP1461438A2 Gene expression construct of hap1 adapted for plant cells |
| 09/29/2004 | EP1461437A2 Expression vectors and promoters for heterologous gene expression |
| 09/29/2004 | EP1461436A1 Polycationic water soluble copolymer and method for transferring polyanionic macromolecules across biological barriers |
| 09/29/2004 | EP1461435A1 A reporter gene |
| 09/29/2004 | EP1461434A2 Compositions, methods and systems for discovery of lipopeptides |
| 09/29/2004 | EP1461433A1 Bacterial superantigen vaccines |
| 09/29/2004 | EP1461432A2 Nucleic acids related to plant retroelements |
| 09/29/2004 | EP1461431A2 Variants of adp-glucose pyrophosphorylase affecting phosphate sensitivity and other parameters |
| 09/29/2004 | EP1461430A2 Ovomucoid promoter and methods of use |
| 09/29/2004 | EP1461429A2 Means for identifying i neisseiria meningitidis /i -specific genes |
| 09/29/2004 | EP1461427A2 Methods for targeted expression of therapeutic nucleic acid |
| 09/29/2004 | EP1461426A1 Eubacterial rna-polymerase mutants with altered product production |
| 09/29/2004 | EP1461425A2 Novel human hydroxylases and polynucleotides encoding the same |
| 09/29/2004 | EP1461422A1 Interleukin-2 gene transferred lymphokine activated killer cells |
| 09/29/2004 | EP1461419A2 Antisense modulation of phospholipid scramblase 3 expression |
| 09/29/2004 | EP1461416A2 Enhanced proteins and methods for their use |
| 09/29/2004 | EP1461360A2 Conjugates comprising an antibody specific for the ed-b domain of fibronectin and their use for the detection and treatment of tumours |
| 09/29/2004 | EP1461359A2 Novel anti-igf-ir antibodies and uses thereof |
| 09/29/2004 | EP1461358A1 Ifnar2 muteins, their production and use |
| 09/29/2004 | EP1461357A2 Novel hev antigenic peptide and methods |
| 09/29/2004 | EP1461352A2 Antisense modulation of connective tissue growth factor expression |
| 09/29/2004 | EP1461351A2 Methods and reagents for diagnosis and treatment of diabetes |
| 09/29/2004 | EP1461350A2 Multiplex real-time quantitative pcr |
| 09/29/2004 | EP1461349A2 Antisense modulation of mhc class ii transactivator expression |
| 09/29/2004 | EP1461348A2 Antisense modulation of phospholipid scramblase 4 expression |
| 09/29/2004 | EP1461155A2 Methods and devices for removal of organic molecules from biological mixtures using anion exchange |
| 09/29/2004 | EP1461119A1 Automatic electroporation optimization system |
| 09/29/2004 | EP1461082A2 Antibodies against carboxic anhydrase ix (ca ix) tumor antigen |
| 09/29/2004 | EP1461081A2 Anti-cd45rb antibodies for use in treating autoimmune disease and transplant rejection |
| 09/29/2004 | EP1461080A2 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
| 09/29/2004 | EP1461079A2 Human immunodeficiency virus envelope clycoprotein mutants and uses thereof |
| 09/29/2004 | EP1461076A2 Methods and compositions for treating lesions of the respiratory epithelium |
| 09/29/2004 | EP1461073A2 Peptide agonists of prostate-specific antigen, and uses therefor |
| 09/29/2004 | EP1461072A1 Proteases producing an altered immunological response and methods of making and using the same |
| 09/29/2004 | EP1461071A1 Muscle transcription factors |
| 09/29/2004 | EP1461064A2 Bovine leptin protein, antisense and antibody |
| 09/29/2004 | EP1461052A2 Nucleic acid injected into hepatic vein lumen and delivered to primate liver |
| 09/29/2004 | EP1461001A2 Cancer-associated epitope |
| 09/29/2004 | EP1460898A1 Wt1 antisense oligos for the inhibition of breast cancer |
| 09/29/2004 | EP1412752A4 Methods and compositions for determining the purity of and purifying chemically synthesized nucleic acids |
| 09/29/2004 | EP1385874A4 Alpha conotoxin peptides with analgesic properties |
| 09/29/2004 | EP1339838A4 Multiple array system for integrating bioarrays |
| 09/29/2004 | EP1322777A4 Methods for reducing complexity of nucleic acid samples |
| 09/29/2004 | EP1218488A4 Site-specific recombination system to manipulate the plastid genome of higher plants |
| 09/29/2004 | EP1206571B1 Rapid and efficient capture of dna from sample without using cell lysing reagent |
| 09/29/2004 | EP1206267B1 Medicaments containing xenogenic oligo- or/and polyribonucleotides |
| 09/29/2004 | EP1183536B1 Fluorescence polarisation assays involving polyions |
| 09/29/2004 | EP1147130A4 Alpha-conotoxin peptides |
| 09/29/2004 | EP1141328B1 Recombinant bacterial strains for the production of natural nucleosides and modified analogues thereof |
| 09/29/2004 | EP1137808B1 Methods for making recombinant cells |
| 09/29/2004 | EP1090116B1 Transgenic non-human animal which comprises an inactive peg3 gene, and the use thereof |
| 09/29/2004 | EP1060185A4 Isolated nucleic acid molecules which encode tage molecules, and uses thereof |
| 09/29/2004 | EP1045922B1 Reconstituting retroviral vector (recon vector) for targeted gene expression |
| 09/29/2004 | EP1042463B1 Target for treating atherosclerosis, obesity and type ii diabetes |
| 09/29/2004 | EP1038013B1 Constitutive plant promoters |
| 09/29/2004 | EP1037664B1 Vaccines containing attenuated bacteria |
| 09/29/2004 | EP1019496B1 In vitro sorting method |
| 09/29/2004 | EP1015012A4 Peptide inhibitors of nuclear protein translocation having nuclear localization sequences and methods of use thereof |
| 09/29/2004 | EP1005486A4 Inducible regulatory system and use thereof |
| 09/29/2004 | EP0994942A4 Improved promoters for enhancing plant productivity |
| 09/29/2004 | EP0989999B1 Antitumoral composition based on immunogenic polypeptide with modified cell location |
| 09/29/2004 | EP0980426B1 TYROSINE PHOSPHORYLATED CLEAVAGE FURROW-ASSOCIATED PROTEINS (PSTPIPs) |
| 09/29/2004 | EP0970119A4 Synaptic activation protein compositions and method |
| 09/29/2004 | EP0956045B1 Assembly-deficient herpesvirus vaccine |
| 09/29/2004 | EP0938572B1 Promoter from tobacco |